Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016043
Filing Date
2022-08-09
Accepted
2022-08-09 16:08:26
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arct-20220630.htm   iXBRL 10-Q 2044925
2 EX-31.1 arct-ex31_1.htm EX-31.1 19923
3 EX-31.2 arct-ex31_2.htm EX-31.2 19881
4 EX-32.1 arct-ex32_1.htm EX-32.1 11035
5 EX-32.2 arct-ex32_2.htm EX-32.2 11002
6 GRAPHIC img265316844_0.jpg GRAPHIC 175304
7 GRAPHIC img265316844_1.jpg GRAPHIC 48127
8 GRAPHIC img265316844_2.jpg GRAPHIC 50999
9 GRAPHIC img265316844_3.jpg GRAPHIC 47146
  Complete submission text file 0000950170-22-016043.txt   7270513

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arct-20220630_pre.xml EX-101.PRE 245410
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arct-20220630_def.xml EX-101.DEF 146673
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arct-20220630.xsd EX-101.SCH 45701
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arct-20220630_lab.xml EX-101.LAB 350822
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arct-20220630_cal.xml EX-101.CAL 38587
55 EXTRACTED XBRL INSTANCE DOCUMENT arct-20220630_htm.xml XML 992610
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 221148323
SIC: 2834 Pharmaceutical Preparations